logo
Trump says he's cut drug prices by up to 1,500%. That's not possible

Trump says he's cut drug prices by up to 1,500%. That's not possible

Economic Times16 hours ago
Synopsis
Donald Trump claimed significant drug price cuts, even up to 1500%. Experts refute this, stating such cuts are impossible. They suggest it would mean people are paid to take medicine. The White House defended Trump, citing price differences with other nations. Trump also mentioned future price drops. Some drugmakers are open to cuts.
AP Days after he sent letters instructing top pharmaceutical manufacturers to use a "most favored nation" pricing model for prescription drugs, President Donald Trump told reporters on Sunday that he had cut costs by up to 1,500%. But Trump's grandiose claim is mathematically impossible. Here's a closer look at the facts. TRUMP: "You know, we've cut drug prices by 1,200, 1,300, 1,400, 1,500%. I don't mean 50%, I mean 14 - 1,500%." THE FACTS: This is false. Cutting drug prices by more than 100% would theoretically mean that people are being paid to take medications. The Trump administration has taken steps to lower prescription drug prices, but experts say there's no indication costs have seen such a massive drop.
Geoffrey Joyce, director of health policy at the University of Southern California's Schaeffer Center, called Trump's claim "total fiction" made up by the Republican president. He agreed that it would amount to drug companies paying customers, rather than the other way around. "I find it really difficult to translate those numbers into some actual estimates that patients would see at the pharmacy counter," said Mariana Socal, an associate professor of health policy and management at Johns Hopkins University who studies the U.S. pharmaceutical market. She added that Trump's math is "really hard to follow." Asked what Trump was using to back up his claim, White House spokesman Kush Desai said: "It's an objective fact that Americans are paying exponentially more for the same exact drugs as people in other developed countries pay, and it's an objective fact that no other Administration has done more to rectify this unfair burden for the American people." The White House provided a chart of price differentials for drugs in the U.S. and comparable countries, but did not offer any other evidence. On Sunday, Trump also described cuts to drug prices as a future development, not that already happened. "So we'll be dropping drug prices," he said. "It will start over the next two to three months by 1,200, 1,300 and even 1,400%." Prices for most prescription drugs - unbranded generics are the exception - are higher in the U.S. than they are in other high-income countries. This is in large part due to the way drug prices are negotiated in the United States. Trump made his recent appeal in letters to 17 pharmaceutical manufacturers, the White House announced last week. He asked them to reduce costs in the U.S. by matching the lowest prices of prescriptions drugs in other comparably developed countries. Some drugmakers have since indicated that they are open to cutting costs. This move follows an executive order Trump signed in May setting a 30-day deadline for drugmakers to electively lower prices in the U.S. or face new limits in the future over what the government will pay. The federal government has the most power to shape the price it pays for drugs covered by Medicare and Medicaid. It's unclear what - if any - impact the Trump administration's efforts will have on millions of Americans who have private health insurance. Socal pointed out that if drug manufacturers had cut costs to the extent Trump claims, they would be shouting it from the rooftops, especially given the heat they've taken over the years for their pricing practices. "My expectation would be that they would make announcements - public announcements - and that those announcements would come way in advance of the actual effective dates when those price cuts would come into effect," she said. Joyce agreed that there has been no indication of a substantial cut. "Not at all, not at all, none whatsoever," he said. "And let alone 1,500."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US to initially impose ‘small tariff' on pharma imports, Trump says
US to initially impose ‘small tariff' on pharma imports, Trump says

Indian Express

time6 minutes ago

  • Indian Express

US to initially impose ‘small tariff' on pharma imports, Trump says

President Donald Trump said on Tuesday that the United States would initially place a 'small tariff' on pharmaceutical imports before hiking it to 150% within 18 months and eventually to 250% in an effort to boost domestic production. 'In one year, one and a half years maximum, it's going to go to 150% and then it's going to go to 250% because we want pharmaceuticals made in our country,' Trump told CNBC in an interview. He did not specify the initial tariff rate on pharmaceuticals. Trump said last month that pharmaceutical tariffs could reach as high as 200%. He said in February that sectoral tariffs on pharmaceuticals and semiconductor chips would start at '25% or higher,' rising substantially over the course of a year. Trump said on Tuesday that he plans to announce tariffs on semiconductors and chips in the 'next week or so,' but gave no further details. The United States has been conducting a national security review of the pharmaceutical sector, and the industry has been preparing for possible sector-specific tariffs. The administration has not announced when the results of that probe will be released. Several drugmakers have pledged multibillion-dollar investments in U.S. manufacturing as Trump threatens import tariffs, with AstraZeneca recently committing $50 billion to expand its American operations. PhRMA, the main lobbying group for the industry, did not immediately respond to a request for comment. A framework agreement between the United States and the EU sets out that tariffs on pharmaceuticals and semiconductors are currently zero, but if the United States raises tariffs following its import investigation, they will be capped at 15%.

Trump says banks discriminate against his supporters while White House prepares order
Trump says banks discriminate against his supporters while White House prepares order

Indian Express

time6 minutes ago

  • Indian Express

Trump says banks discriminate against his supporters while White House prepares order

US President Donald Trump on Tuesday said he believes that banks discriminate against him and his supporters, adding that Bank of America and JPMorgan Chase had previously refused to accept his deposits. 'They totally discriminate against, I think, me maybe even more, but they discriminate against many conservatives,' he told CNBC in an interview. 'I think the word might be Trump supporters more than conservatives.' Trump made the comments when asked about a report by the Wall Street Journal that said he planned to punish banks that discriminated against conservatives, but did not address the order specifically. The order instructs regulators to review banks for 'politicized or unlawful debanking' practices, according to a draft reviewed by Reuters. 'Well, they did discriminate,' Trump said of actions taken by JPMorgan Chase after his first term in office. 'I had hundreds of millions, I had many, many accounts loaded up with cash … and they told me, 'I'm sorry sir, we can't have you. You have 20 days to get out.'' Trump said, without providing evidence, that he believed that the banks' refusal to take his deposits indicated that the administration of former President Joe Biden had encouraged banking regulators to 'destroy Trump.' Trump said he subsequently tried to deposit funds with Bank of America and was also refused, and eventually split the cash among a number of smaller banks. 'The banks discriminated against me very badly,' he said. In a statement, JPMorgan did not address the president's specific claim that it had discriminated against him. 'We don't close accounts for political reasons, and we agree with President Trump that regulatory change is desperately needed,' JPMorgan said. 'We commend the White House for addressing this issue and look forward to working with them to get this right.' Bank of America also did not address Trump's specific claims in the CNBC interview. 'REPUTATIONAL RISK' ISSUE During President Joe Biden's administration, regulators could have asked the banks why they were providing banking services to Trump because of the 'reputational risk' issue, a source familiar with the matter said. Another source said that banks were under intense scrutiny and pressure with regards to what qualified as a reputational risk for banks and they needed to be careful due to Trump's legal entanglements. The source also added that at present JPMorgan continues to have a banking relationship with members of the Trump family that dates back to years ago and that they also bank a number of campaign accounts related to Trump. After President Trump took power, the Federal Reserve announced in June it was directing its supervisors to no longer consider 'reputational risk' when examining banks, scrapping a metric that had been a focus of industry complaints. The Wall Street Journal reported late Monday that the expected executive order would instruct regulators to investigate whether any financial institutions breach the Equal Credit Opportunity Act, antitrust laws or consumer financial protection laws by dropping customers for political reasons. It said the order could be signed as early as this week, authorizing monetary penalties, consent decrees or other disciplinary measures against violators. The White House had no immediate comment on the reported order. 'What the White House is doing is telling the banks not to hide behind regulations to deny loans or banking relationships,' said Wells Fargo bank analyst Mike Mayo. 'The banks can use their normal underwriting standards and deny services, but not blame regulators or use reputational risk as a justification.' Bank of America said it welcomed the Trump administration's efforts to provide regulatory clarity to banks. 'We've provided detailed proposals and will continue to work with the administration and Congress to improve the regulatory framework,' the bank said. Trump in January said the CEOs of JPMorgan Chase and Bank of America denied services to conservatives. At the time, the two banks denied making banking decisions based on politics. 'This seems to be rhetoric that will likely be forgotten by lunchtime,' said David Wagner, head of equities at Aptus Capital Advisors. 'I don't see any material impact on banks, as there are many other drivers that will ultimately presage performance for banks, such as deregulation.' JPMorgan and Bank of America shares both fell over 1%, in line with a decline for the broader S&P Bank index. Banks have consistently argued that any complaints about 'debanking' should be aimed at regulators, as they argue onerous rules and bank supervisors policing firms can discourage them from engaging in certain activities. 'The heart of the problem is regulatory overreach and supervisory discretion,' the Bank Policy Institute, an industry group, said in a statement. 'The banking agencies have already taken steps to address issues like reputational risk, and we're hopeful that any forthcoming executive order will reinforce this progress by directing regulators to confront the flawed regulatory framework that gave rise to these concerns in the first place.'

‘Trump will be impeached again...': Democrats erupt in fury over GOP's Texas redistricting plan
‘Trump will be impeached again...': Democrats erupt in fury over GOP's Texas redistricting plan

Time of India

time6 minutes ago

  • Time of India

‘Trump will be impeached again...': Democrats erupt in fury over GOP's Texas redistricting plan

At a press conference in Chicago, Texas House Democrats strongly pushed back against the GOP's redistricting plan and the contentious decision to issue civil arrest warrants for Democratic lawmakers who left the state. Representatives Jasmine Crockett and Al Green were among those who condemned the Republican actions, calling them politically driven and a threat to democratic principles. Show more Show less

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store